Stock exchanges
Stock Yards Bancorp, Inc., a Kentucky-based banking company, has appointed David L. Hardy to its Board of Directors, effective upon the commencement of the Board's next regularly scheduled meeting on October 21, 2025. Mr. Hardy, 60, fills the vacancy created by the retirement of David Heintzman. He will
Stock offerings
Synergy CHC Corp., a leading consumer health and wellness company, has announced the pricing of an underwritten public offering of 1,750,000 shares of common stock at a public offering price of $2.50 per share. The gross proceeds from the offering are expected to be $4.375 million,
Stock offerings
Advanced Materials, Inc., a development stage company focused on becoming a global leader in specialty boron and advanced boron derivative materials, has announced the pricing of its underwritten public offering of common stock in the United States. The company is selling 2,374,481 shares of common stock at a
Securities law
Tyra Biosciences has filed a Form 8-K with the U.S. Securities and Exchange Commission, announcing that the first child has been dosed in the BEACH301 Phase 2 clinical study of dabogratinib (formerly TYRA-300) in children with achondroplasia. The Company expects to report initial results from the safety sentinel cohort
Securities law
The DC Circuit Court of Appeals recently struck down the Securities and Exchange Commission's (SEC) 2020 Proxy Advisor Rule, allowing unaccountable proxy advisors to continue manipulating important voting decisions affecting thousands of companies without recourse. This ruling enables the duopoly of proxy advisors, Glass Lewis and Institutional Shareholder
Securities law
A cybersecurity incident has affected Inotiv, Inc.'s systems and data, causing disruptions to certain business operations and potentially impacting the company's financial condition. The company is working to contain, assess, and remediate the incident, although the full scope and nature of the impacts are not yet
Securities law
BiomX Inc. has filed a Form 8-K with the U.S. Securities and Exchange Commission announcing that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on the Company's Phase 2b study for its drug candidate BX004 in treating Cystic Fibrosis (CF). The FDA
Stock exchanges
Telos Corporation, a prominent technology company, has filed a Current Report with the U.S. Securities and Exchange Commission, addressing recent fluctuations in its stock price. Following the release of the company's second quarter 2025 financial results on August 11, 2025, some investors questioned whether Telos might consider
Stock exchanges
Bolt Projects Holdings, Inc. has entered into a securities purchase agreement with investors, which includes the sale of common stock and pre-funded warrants. The agreement, dated August 14, 2025, outlines the terms of the transaction, including the issuance of 913,979 shares of common stock and pre-funded warrants to purchase
Securities law
Hudson Global, Inc. has filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission on August 14, 2025, following the company's announcement of a proposed merger with Star Equity Holdings, Inc. The merger, subject to the satisfaction or waiver of certain conditions, will
Financial markets
The Securities and Exchange Commission (SEC) has released draft guidelines aimed at providing clarity on exempt transactions under the Securities Regulation Code (SRC). This move is part of the commission's efforts to simplify business operations and establish clear guidelines for potential players in the capital market. The draft
Financial markets
President Luiz Inácio Lula da Silva is set to approach the Senate leadership to clear the way for the government's nominations to lead the Brazilian Securities and Exchange Commission (CVM), as the powerful congressional bloc, Centrão, seeks leadership positions at regulatory agencies. The CVM has two vacant board
